Stock listing
TPEx:6986 HeXun Biosciences Co Ltd (和迅) 股價
Follow HeXun Biosciences Co Ltd into a list and get an email when it puts out news.
Share price · TPEX:6986
$36.90 TWD -2.80 (-7.1%)
Close on Nov 20, 2026
- Day range
- $35.10 – $37.10 TWDNov 20, 2026
- Volume
- 60,065 sharesNov 20, 2026
- Market cap
- $1.89B TWDAt the close on Nov 20, 2026 · price × 51.09M shares outstanding
- 52-week range
- $35.10 – $71.60 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.81M TWDMedian day 54,085 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6986 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $36.90 | -2.80 | -7.1% | $36.40 | $37.10 | $35.10 | 60,065 | |
| $39.70 | -0.35 | -0.9% | $40.15 | $40.15 | $37.25 | 29,025 | |
| $40.05 | +0.55 | +1.4% | $40.45 | $40.45 | $37.40 | 48,001 | |
| $39.50 | -0.50 | -1.3% | $40.00 | $40.00 | $37.85 | 11,068 | |
| $40.00 | +2.50 | +6.7% | $37.50 | $41.20 | $37.10 | 94,000 | |
| $37.50 | 0.00 | 0.0% | $39.15 | $39.20 | $36.80 | 63,012 | |
| $37.50 | +0.20 | +0.5% | $36.55 | $37.50 | $35.60 | 55,169 | |
| $37.30 | -1.70 | -4.4% | $39.10 | $39.85 | $36.25 | 178,979 | |
| $39.00 | -1.10 | -2.7% | $40.10 | $40.10 | $39.00 | 27,207 | |
| $40.10 | -2.35 | -5.5% | $39.50 | $40.15 | $39.50 | 81,270 | |
| $42.45 | -0.55 | -1.3% | $43.05 | $43.15 | $41.80 | 72,154 | |
| $43.00 | -0.15 | -0.3% | $43.50 | $43.50 | $42.90 | 59,075 | |
| $43.15 | -0.15 | -0.3% | $43.20 | $43.90 | $42.85 | 99,120 | |
| $43.30 | 0.00 | 0.0% | $43.30 | $43.50 | $43.30 | 29,047 | |
| $43.30 | -0.30 | -0.7% | $43.80 | $43.80 | $43.30 | 40,300 | |
| $43.60 | -0.15 | -0.3% | $43.75 | $43.75 | $43.60 | 14,000 | |
| $43.75 | +0.05 | +0.1% | $43.75 | $43.75 | $43.70 | 15,055 | |
| $43.70 | -0.10 | -0.2% | $43.85 | $43.85 | $43.70 | 12,000 | |
| $43.80 | 0.00 | 0.0% | $43.80 | $43.80 | $43.80 | 0 | |
| $43.80 | -0.85 | -1.9% | $42.80 | $44.65 | $42.80 | 52,647 | |
| $44.65 | +0.25 | +0.6% | $44.55 | $45.00 | $44.40 | 44,012 | |
| $44.40 | -0.10 | -0.2% | $44.70 | $44.70 | $44.35 | 10,019 | |
| $44.50 | -0.25 | -0.6% | $44.75 | $44.75 | $44.45 | 44,615 | |
| $44.75 | +0.75 | +1.7% | $44.15 | $44.80 | $44.05 | 74,000 | |
| $44.00 | -0.15 | -0.3% | $44.15 | $44.20 | $44.00 | 73,000 | |
| $44.15 | +0.10 | +0.2% | $44.05 | $44.35 | $44.05 | 20,000 | |
| $44.05 | 0.00 | 0.0% | $44.00 | $44.15 | $43.90 | 76,000 | |
| $44.05 | -0.25 | -0.6% | $44.40 | $44.40 | $43.95 | 46,000 | |
| $44.30 | +0.10 | +0.2% | $44.00 | $44.30 | $44.00 | 35,000 | |
| $44.20 | +0.20 | +0.5% | $43.80 | $44.45 | $43.80 | 53,000 | |
| $44.00 | 0.00 | 0.0% | $44.00 | $44.00 | $43.90 | 146,000 | |
| $44.00 | 0.00 | 0.0% | $43.90 | $44.00 | $43.05 | 86,017 | |
| $44.00 | 0.00 | 0.0% | $44.10 | $44.10 | $43.90 | 213,000 | |
| $44.00 | -0.05 | -0.1% | $44.90 | $44.90 | $43.90 | 180,000 | |
| $44.05 | +0.05 | +0.1% | $44.05 | $44.25 | $44.00 | 148,000 | |
| $44.00 | -0.30 | -0.7% | $44.30 | $44.30 | $42.80 | 67,000 | |
| $44.30 | -1.20 | -2.6% | $45.90 | $45.90 | $44.00 | 44,000 | |
| $45.50 | +0.25 | +0.6% | $45.25 | $45.90 | $44.80 | 127,000 | |
| $45.25 | +1.05 | +2.4% | $42.60 | $46.40 | $41.50 | 160,000 | |
| $44.20 | +4.00 | +10.0% | $40.80 | $44.20 | $40.30 | 217,000 | |
| $40.20 | -0.20 | -0.5% | $40.50 | $40.50 | $39.40 | 104,010 | |
| $40.40 | -0.10 | -0.2% | $40.25 | $40.40 | $40.20 | 37,000 | |
| $40.50 | +0.25 | +0.6% | $40.30 | $40.50 | $40.05 | 44,000 | |
| $40.25 | -0.10 | -0.2% | $40.10 | $40.50 | $40.10 | 21,000 | |
| $40.35 | -0.10 | -0.2% | $41.00 | $41.20 | $40.00 | 38,000 | |
| $40.45 | -0.20 | -0.5% | $40.35 | $40.60 | $40.10 | 59,000 | |
| $40.65 | -0.10 | -0.2% | $40.65 | $42.20 | $40.60 | 48,005 | |
| $40.75 | -0.55 | -1.3% | $41.00 | $41.00 | $40.05 | 65,000 | |
| $41.30 | -0.20 | -0.5% | $40.85 | $41.30 | $40.75 | 107,000 | |
| $41.50 | -0.30 | -0.7% | $41.60 | $41.60 | $40.80 | 63,035 | |
| $41.80 | +0.30 | +0.7% | $41.95 | $42.20 | $40.10 | 64,000 | |
| $41.50 | -1.00 | -2.4% | $42.20 | $42.65 | $40.50 | 45,000 | |
| $42.50 | -0.40 | -0.9% | $42.80 | $42.95 | $42.05 | 37,000 | |
| $42.90 | 0.00 | 0.0% | $43.90 | $43.90 | $42.35 | 53,000 | |
| $42.90 | +1.30 | +3.1% | $40.80 | $43.50 | $40.80 | 65,000 | |
| $41.60 | -0.10 | -0.2% | $41.05 | $41.70 | $40.05 | 76,000 | |
| $41.70 | -0.05 | -0.1% | $41.85 | $41.90 | $41.70 | 45,000 | |
| $41.75 | -0.55 | -1.3% | $41.90 | $42.30 | $41.65 | 31,034 | |
| $42.30 | -0.50 | -1.2% | $42.80 | $42.80 | $40.70 | 59,000 | |
| $42.80 | -0.20 | -0.5% | $42.90 | $43.00 | $42.50 | 31,000 | |
| $43.00 | -0.10 | -0.2% | $43.30 | $43.35 | $42.80 | 40,000 | |
| $43.10 | +0.20 | +0.5% | $43.20 | $43.20 | $42.45 | 59,000 |
- Ticker
- TPEx:6986
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest deck · Jul 16, 2026
和迅生技產業論壇 2026
Conference · 43 slides
HeXun Biosciences Co Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 3 decks · latest Jul 16, 2026
Valuation
EV/sales 3.4× against a median of 8.5×: 2nd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.06B TWD
- P/E
- 16.2×
- EV/sales
- 3.4×
- EV/EBITDA
- 6.5×
- Price/book
- 1.8×
- Gross margin
- 91.0%
- Operating margin
- 42.4%
- Net margin
- 37.7%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| HeXun Biosciences Co Ltd · TPEX:6986 | US$57.20M | US$32.05M | 16.2× | 3.4× | 6.5× | 1.8× | 37.7% | 0.0× | n/a |
| Rani Therapeutics Holdings, Inc. · NASDAQ:RANI | US$58.99M | US$16.85M | n/a | 2.6× | n/a | 1.7× | −493.0% | 0.1× | 2.21 |
| iNtRON Biotechnology, Inc. · KRX:048530 | US$57.05M | US$31.20M | n/a | 5.8× | n/a | 1.2× | −142.6% | 0.0× | n/a |
| Tenax Therapeutics, Inc. · NASDAQ:TENX | US$56.92M | −US$56.78M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.35 |
| Kazia Therapeutics Ltd · NASDAQ:KZIA | US$56.22M | US$10.34M | n/a | 372× | n/a | 1.8× | n/a | 0.0× | 2.31 |
| OKYO Pharma Limited · NASDAQ:OKYO | US$56.15M | US$35.56M | n/a | n/a | n/a | 4.5× | n/a | 0.0× | 1.02 |
| Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704 | US$55.78M | US$51.66M | n/a | 9.1× | n/a | 2.5× | −43.0% | 0.3× | n/a |
| Cognition Therapeutics, Inc. · NASDAQ:CGTX | US$55.37M | US$25.10M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | 2.28 |
| EyeGene, Inc. · KRX:185490 | US$55.25M | US$26.51M | n/a | 8.0× | n/a | 1.5× | −391.5% | 0.0× | n/a |
| AB Science SA · EURONEXT:AB | US$55.18M | US$50.52M | n/a | 39.2× | n/a | n/a | −132.6% | n/a | n/a |
| Azora Therapeutics, Inc. · NASDAQ:AZR | US$55.00M | US$33.00M | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 |
| Median of the others | US$55.97M | US$28.85M | 8.5× | 1.8× | −142.6% | 0.0× | 1.78 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 和迅生技產業論壇 2026 | Conference | 43 slides | Jul 16, 2026 |
| Investor Presentation (May 2026) | Investor deck | 53 slides | May 29, 2026 |
| Investor Presentation (August 2024) | Investor deck | 54 slides | Aug 2, 2024 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 293.2M | 286.4M | 130.6M | 49.5M | 0 |
| Cost of revenue | 26.9M | 25.7M | 16.8M | 4.86M | 0 |
| Gross profit | 266.3M | 260.7M | 113.7M | 44.6M | 0 |
| Research and development | 99.2M | 65.4M | 53.2M | 39.4M | 44.7M |
| Selling, general and administrative | 49.1M | 35.4M | 29.6M | 13.5M | 5.95M |
| Operating income | 118.0M | 155.7M | 27.4M | -3.55M | -50.7M |
| Depreciation and amortization | 28.9M | 24.7M | 20.3M | 14.7M | 11.9M |
| EBITDA | 146.9M | 180.4M | 47.7M | 11.2M | -38.8M |
| Interest expense | 1.11M | 1.18M | 1.85M | 1.64M | 1.57M |
| Income before tax | 125.9M | 161.5M | 33.5M | -5.19M | -43.0M |
| Income tax | 14.2M | ||||
| Net income | 111.9M | 147.2M | 33.5M | -5.19M | -43.0M |
| Earnings per share, basic | 2.43 | 3.20 | 0.89 | -0.14 | -1.41 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 208.2M | 201.0M | 257.7M | 119.7M | 85.0M | 71.7M |
| Short-term investments | 301.4M | 172.0M | 72.0M | 72.0M | ||
| Receivables | 74.2M | 84.7M | 22.3M | 4.98M | 0 | |
| Inventory | 6.02M | 15.6M | 4.60M | 0 | ||
| Current assets | 609.6M | 483.2M | 363.7M | 211.2M | 93.4M | 78.7M |
| Total assets | 837.1M | 706.9M | 571.4M | 404.2M | 294.6M | 266.2M |
| Accounts payable | 3.17M | 4.24M | 4.98M | 5.44M | 3.40M | 2.55M |
| Current liabilities | 62.5M | 53.8M | 30.2M | 20.0M | 7.83M | 11.8M |
| Long-term debt | 0 | 34.9M | 37.3M | 39.4M | ||
| Total debt | 35.0M | 70.1M | 69.4M | 74.1M | 80.9M | |
| Total liabilities | 95.5M | 86.3M | 98.1M | 89.3M | 79.9M | 86.5M |
| Shareholders' equity | 741.6M | 620.6M | 473.4M | 314.9M | 214.8M | 179.7M |
| Shares outstanding | 46.0M | 46.0M | 37.5M | 37.5M | 30.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 163.9M | 120.9M | 43.1M | 11.2M | -35.5M |
| Capital spending | -28.9M | -37.3M | -22.8M | -1.23M | 0 |
| Free cash flow | 135.0M | 83.6M | 20.3M | 10.0M | -35.5M |
| Cash from investing | -137.3M | -25.3M | -79.0M | -26.9M | |
| Cash from financing | -40.3M | 120.1M | 102.5M | 75.8M | |
| Change in cash | 7.21M | -56.7M | 137.9M | 34.7M | 13.3M |
Cap table
Built by 6ix from HeXun Biosciences Co Ltd’s releases
- Common shares
- 51,090,000
- Fully diluted
- 51,090,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 51,090,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 51,090,000 |
Log in to ask 6ix AI your own questions about HeXun Biosciences Co Ltd.